Conrig Pharma Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private

Conrig Pharma General Information

Description

Developer of drugs intended to combat cough, atopic diseases and serious respiratory disorders. The company leverages molecular modifications in order to improve pharmacokinetic properties in the reposition of drug molecules with safety and efficacy profiles, enabling the medical community to efficiently treat chronic cough and illnesses.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Ole Maaløes vej 3
  • 2200 Copenhagen
  • Denmark
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Conrig Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private Completed Clinical Trials - Phase 2
1. Early Stage VC Completed Startup
To view Conrig Pharma’s complete valuation and funding history, request access »

Conrig Pharma Executive Team (3)

Name Title Board Seat Contact Info
John Hansen Ph.D Co-Founder, Chief Executive Officer & Board Member
Niels Skjærbæk Ph.D Chief Operating Officer & Board Member
Mikael Thomsen Ph.D Co-Founder, Board Member & Chief Scientific Officer
To view Conrig Pharma’s complete executive team members history, request access »

Conrig Pharma Board Members (4)

Name Representing Role Since
John Hansen Ph.D Conrig Pharma Co-Founder, Chief Executive Officer & Board Member 000 0000
Niels Skjærbæk Ph.D Conrig Pharma Chief Operating Officer & Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »